Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access